On 11 April 2012, Johnson & Johnson and its subsidiary Janssen Pharmaceuticals Inc. were fined $1.2 billion by Judge Timothy Davis Fox of the Sixth Division of the Sixth Judicial Circuit of the U.S. state of Arkansas.[26] The jury found the companies had downplayed multiple risks associated with risperidone (Risperdal). The judge held that nearly 240,000 violations of the state's Medicaid fraud law had been committed. Each violation carried a $5,000 fine. The companies were also fined $11 million for more than 4,500 violations of the state’s deceptive practices laws.
According to the Wall Street Journal on June 20, 2012, "Johnson & Johnson and the U.S. Justice Department [we]re close to settling a protracted investigation into the company’s promotion of the antipsychotic Risperdal, for what would be one of the highest sums to date in a drug-marketing case. The sides are trying to wrap together a number of lawsuits, state investigations and other probes of alleged illegal marketing, and are discussing a payment of $1.5 billion or higher."
In August 2012, Johnson & Johnson agreed to pay $181 million to 36 U.S. states in order to settle claims that it had promoted risperidone for off-label uses including for dementia, anger management, and anxiety.[27]
که خیلی م سریعِ مراحلش. ینی طی یه ماه جلسات هیپنوتیزم خوب می شی. ولی روان درمانی 6 ماه مثلن طول میکشه برای افسردگیِ شدید.
من به شخصه روان درمانی رو ترجیح می دم.
من ی مدت مدیدی خوردم ب اصرار مادرم(خیلیا میخورن نه صرفا افسرده ها..اصلا انگار اپیدمی شده)بعد دیدم واقعا بخورم نخورم فرقی نداره تو حالم 
خب تو همچین حالتی چرا بخوردش آدم؟
